Beta blockers for peripheral arterial disease

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Paravastu, Sharath Chandra Vikram ^b   Mendonca, Derick ^a   Da Silva, Anthony ^a  

^a WREXHAM MAELOR HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CELIPROLOL; ISOSORBIDE; ISOXSUPRINE; LABETALOL; METHYLDOPA; METOPROLOL; NIFEDIPINE; PINDOLOL; PLACEBO; PROPRANOLOL; TERTATOLOL;

ARTERY DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; DATA ANALYSIS; DATA EXTRACTION; DRUG EFFECT; DRUG WITHDRAWAL; EXERCISE; GASTROCNEMIUS MUSCLE; HUMAN; INFORMATION PROCESSING; INTERMITTENT CLAUDICATION; INTERVENTION STUDY; ISCHEMIA; MUSCLE BLOOD FLOW; OUTCOME ASSESSMENT; PUBLICATION; REVIEW; RISK; SCIENTIFIC LITERATURE; SKIN TEMPERATURE; TIME; TREADMILL; VASCULAR RESISTANCE; WALKING;

EID: 55049115477     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005508.pub2     Document Type: Review

References (39)

1. Clement 1980 {published data only} Clement DL. Studies on the effect of alpha- and beta- adrenergic blocking agents on the circulation in human limbs. Verhandelingen Van De Koninklijke Academie voor Geneekunde van Belgie 1980;XLII (3-4)(42):164-214.
2. Hiatt 1985 {published data only} Hiatt WR, Stoll S, Nies AS. Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease. Circulation 1985;72(6):1226-31.
3. Lepantalo 1984a {published data only} Lepantalo M. Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication. British Journal of Clinical Pharmacology 1984;18(1):90-3.
4. Lepantalo 1985 {published data only} Lepantalo M. Chronic effects of labetalol, pindolol, and propranolol on calf blood flowin intermittent claudication. Clinical Pharmacology and Therapeutics 1985;37(1):7-12.
5. Roberts 1987 {published data only} Roberts DH, Tsao Y, McLoughlin GA, Breckenridge A. Placebo controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication. Lancet 1987;ii:(8560):650-3.
6. Solomon 1991 {published data only} Solomon SA, Ramsay LE, Yeo WW, Parnell L, Morris-Jones W. Beta-Blockade and intermittent claudication: placebo controlled trial of atenolol, nifedipine and their combination. BMJ 1991;303(6810):1100-4.
7. Aarts 1986 {published data only} Aarts PA, Banga JD, van Houwelingen HC, Heethaar RM, Sixma JJ. Increased red blood cell deformability due to isoxsuprine administration decreases platelet adherence in a perfusion chamber: A double-blind cross-over study in patients with intermittent claudication. Blood 1986;67(5):1474-81.
8. Bogaert 1983 {published data only} Bogaert MG, Clement DL. Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication. European Heart Journal 1983;4(3):203-4.
9. Bostrom 1986 {published data only} Bostrom PA, Janzon L, Ohlsson O, Westergren A. The effect of beta-blockade on leg blood flow in hypertensive patients with intermittent claudication. Angiology 1986;37(3 pt1):149-53.
10. Brown 1998 {published data only} Brown MJ, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Journal of Hypertension 1998;16(12):2113-6. [MEDLINE: 4769]
11. Diehm 1993 {published data only} Diehm C, Jacobsen O, Amendt K. The effects of tertalolol on lipid profile. Cardiology 1993;83 Suppl 1:32-40.
12. Forbes 1999 {published data only} Forbes CD, Lowe GD, Maclaren M, Shaw BG, Dickinson JP, Keiffer G. Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a betablocker and a calcium uptake antagonist. Seminars in Thrombosis and Hemostasis 1999;25 Suppl 2:55-60.
13. Iarussi 1977 {published data only} Iarussi D, Ferrante MR, Garofalo S, De Cristofaro M. Instrumental evaluation of the effects of a delayed-action preparation of a isoxsuprine on the peripheral circulation [Valutazione strumentale degli effetti sul circolo periferico di un preparato di isossisuprina ad azione protratta.]. La Clinica Terapeutica 1977;80(4):315-25.
14. Karnik 1987 {published data only} Karnik R, Valentin A, Slany J. Different effects of beta-1-adrenergic blocking agents with ISA or without ISA on peripheral blood flow. Angiology 1987;38(4):296- 303.
15. Klieber 1986 {published data only} Klieber M, Resch F. Comparative studies of the effect of a cardioselective and a non-cardioselective betablocker on peripheral circulation in patients with arterial occlusive disease. Wiener Klinische Wochenschrift 1986;98(3):70-3.
16. Konecny 1986 {published data only} Konecny U, Ehringer H, Rasser W, Koppensteiner R, Minar E, Wachter M. The acute effect of celiprolol I.V. on the resting blood flow of calf and foot in healthy subjects and patients with peripheral arterial occlusive disease (PAOD). What is New in Angiology? Trends and Controversies. Zuckschwerdt, W, 1986:541-2.
17. Lepantalo 1984b {published data only} Lepantalo M, von Knorring J. Walking capacity of patients with intermittent claudication during chronic antihypertensive treatment with metoprolol and methyldopa. Clinical Physiology 1984;4(4):275-82.
18. Lepantalo 1986 {published data only} Lepantalo M, Lindstorm BL, Totterman KJ. Adrenoreceptor blocking drugs and cold feet in intermittent claudication. VASA 1986;15(2):135-7.
19. Novo 1985 {published data only} Novo S, Pinto A, Galati D, Giannola A, Forte G, Strano A. Effects of chronic administration of selective betablockers on peripheral circulation of lower limbs in patients with essential hypertension. International Angiology 1985;4(2):229-34.
20. Novo 1986 {published data only} Novo S, Alaimo G, Abrignani MG, Giordano U, Avellone G, Pinto A, et al.Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arterioscleorsis obliterans of the lower limb. International Journal of Clinical and Pharmacology Research 1986;6(3):199-211.
21. Reichert 1975 {published data only} Reichert N, Shibolet S, Adar R, Gafni J. Controlled trial of propranolol in intermittent claudication. Clinical Pharmacology and Therapeutics 1975;17(5):612-5.
22. Schweizer 1996 {published data only} Schweizer J, Kaulen R, Altmann E, Nierade A, Nanning T. Are beta-blockers generally contraindicated in patients with peripheral arterial occlusive disease?. Zeitschrift fur Kardiologie 1996;85(3):193-7.
23. Schweizer 1997 {published data only} Schweizer J, Kaulen R, Nierade A, Altman E. Beta blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings. VASA 1997;26(1): 43-6.
24. Skotnicki 1984 {published data only} Skotnicki SH, van Gaal G, Wijn PF. The effectiveness of Isoxsuprine in patients with intermittent claudication. Angiology 1984;35(11):685-93.
25. Smith 1982 {published data only} Smith RS, Warren DJ. Effect of beta-blocking drugs on peripheral blood flow in intermittent claudication. Journal of Cardiovascular Pharmacology 1982;4(1):2- 4.
26. Strandness 1970 {published data only} Strandness D Jr. Ineffectiveness of isoxsuprine on intermittent claudication. JAMA 1970;213(1):86-8.
27. Svendsen 1985 {published data only} Svendsen TL, Jelnes R, Tonnesen KH. Is adrenergic betareceptor blockade contraindicated in patients with intermittent claudication. Acta Medica Scandinavica 1985;693:129-32.
28. Svendsen 1986 {published data only} Svendsen TL, Jelnes R, Tonnesen KH. The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication. Acta Medica Scandinavica 1986;219(2):161-5.
29. ACC/AHA 2003 American College of Cardiologists/American Heart Association. Guidelines: Class 1 indications of beta-blockers. www.acc.org.
30. BNF 2007 Joint Formularly Committee. British National Formulary. Vol. 54, London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2007.
31. Criqui 1985 Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71(3):510-5.
32. George 1974 George CF. Beta-receptor blocking agents. Prescribers Journal 1974;14:93-8.
33. Hiatt 2001 Hiatt WR. Medical treatment of peripheral arterial disease and claudication. New England Journal of Medicine 2001;344(21):1608-21.
34. Hughson 1978 Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. British Medical Journal 1978;1(6124):1379-81.
35. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomised clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
36. Kannel 1985 Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. Journal of the American Geriatrics Society 1985;33(1):13-8.
37. Lassila 1986 Lassila R, Lepantalo M, Lindfors O. Peripheral arterial disease - natural outcome. Acta Medica Scandinavica 1986;220(4):295-301.
38. MIAMI trial MIAMI Trial Researchers. Metoprolol in acute myocardial infarction. Other clinical findings and tolerability. The MIAMI Trial Research Group. American Journal of Cardiology 1985;56(14):G39- G46.
39. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.